Experimental observations on dissolution of uric acid calculi

Uric acid stones are a common type of kidney stone, and their dissolution is a key clinical goal. Prior research has shown that various solutions can dissolve these stones, but the effectiveness depends on factors like pH and concentration. However, no prior work had resolved how different concentrations and pH levels influence dissolution rates in real-world conditions. This gap motivated the need for an in vitro model to test dissolution efficacy. Existing methods have limitations in predicting clinical outcomes due to variability in stone composition and solution interactions. The need for a controlled experimental setup became apparent to guide clinical practice. This study addresses the lack of standardized protocols for dissolution. No prior work had confirmed in vivo the in vitro dissolution rates of uric acid stones. This study bridges the gap between laboratory findings and clinical application.

The aim of this study was to evaluate the efficacy of different irrigating solutions for dissolving uric acid stones. The specific problem addressed was the variability in dissolution rates observed in clinical settings. The motivation was to identify optimal conditions for rapid and complete dissolution. The study sought to compare Tris (hydroxymethyl) aminomethane with sodium bicarbonate. It aimed to determine the best concentration and pH for each solution. The authors wanted to confirm whether in vitro results could be replicated in vivo. This would help clinicians choose the most effective dissolution strategy. The study also aimed to prevent the formation of protective stone coatings during dissolution.

The study used an in vitro model to simulate the dissolution of uric acid calculi. Uric acid stones were placed in solutions of varying concentrations and pH levels. The primary solutions tested were Tris (hydroxymethyl) aminomethane and sodium bicarbonate. Dissolution rates were measured over time to compare the effectiveness of each solution. The highest pH levels and concentrations were tested to find optimal conditions. The model also assessed whether protective coatings formed on the stones. An in vivo component was conducted using pigs with surgically placed human stones. The in vivo results were compared to the in vitro findings to validate the model.

Tris (hydroxymethyl) aminomethane dissolved uric acid stones significantly faster than sodium bicarbonate. The fastest dissolution occurred at a pH of 10.5 and concentrations of 0.2 M or higher. Stones with an average diameter of 1 cm were fully dissolved in under 48 hours. Sodium bicarbonate showed reduced effectiveness at higher concentrations and pH levels. At concentrations above 0.2 M and pH above 9, sodium urate coatings formed on the stones. These coatings prevented further dissolution and reduced clinical utility. The in vitro findings were confirmed in a limited in vivo study using pigs. The recommended clinical protocol was 0.3 M THAM-E at a flow rate of 50 cc per hour.

The authors concluded that Tris (hydroxymethyl) aminomethane is more effective than sodium bicarbonate for dissolving uric acid stones. They proposed that the highest dissolution rates occur at pH 10.5 and concentrations of 0.2 M or above. The study suggests that THAM-E is optimal for clinical use due to its rapid dissolution effect. Sodium bicarbonate should be used with caution at lower concentrations and pH levels. The formation of sodium urate coatings at higher concentrations limits its utility. The in vivo results support the in vitro findings and validate the model. The authors recommend a 0.3 M concentration of THAM-E at a flow rate of 50 cc per hour. These findings provide a practical guide for clinicians to achieve rapid stone dissolution.